Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 13/20 | 0.57 |
| ▸ | HDAC3 | O15379 | 6/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 6/20 | 0.57 |
| ▸ | VNN1 | O95497 | 3/20 | 0.51 |
| ▸ | KDM1A | O60341 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24968633 | 0.78 | HDAC6 (0.67) | HDAC6HDAC3HDAC1HDAC2VNN1 | |
| SCHEMBL28247594 | 0.78 | HDAC6 (0.66) | HDAC6HDAC3HDAC1HDAC2VNN1 | |
| SCHEMBL18742382 | 0.76 | HDAC6 (0.82) | HDAC6HDAC3HDAC1HDAC2VNN1 | |
| SCHEMBL28247610 | 0.74 | HDAC6 (0.61) | HDAC6HDAC3HDAC1HDAC2VNN1 | |
| SCHEMBL28248169 | 0.73 | HDAC6 (0.60) | HDAC6HDAC3HDAC1HDAC2VNN1 | |
| SCHEMBL4729657 | 0.73 | HDAC3 (1.00) | HDAC6HDAC3HDAC1HDAC2VNN1 | |
| SCHEMBL18742434 | 0.72 | HDAC6 (0.78) | HDAC6HDAC3HDAC1HDAC2VNN1 | |
| SCHEMBL22804912 | 0.72 | HDAC6 (0.60) | HDAC6HDAC3HDAC1HDAC2VNN1 | |
| SCHEMBL29581928 | 0.72 | HDAC6 (0.60) | HDAC6HDAC3HDAC1HDAC2VNN1 | |
| SCHEMBL18742577 | 0.72 | HDAC3 (0.75) | HDAC6HDAC3HDAC1HDAC2VNN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017065473-A1 | OXADIAZOLE AMINE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2017-04-20 | — | — | WO | disclosed |